ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
Prof Ken Mills speaks with ecancer at the HARMONY Project general assembly 2018 in Valencia.
He outlines the value of big data for diseases such as blood cancer.
To see more from HARMONY visit their website.
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
Hormonal receptor positive breast cancer adjuvant and metastatic indications
Multiple myeloma in a resource constrained setting
Synthetic biology and precision medicine in blood and gynaecological cancers
Relapsed refractory multiple myeloma
OncoAlert Round Up for August 25th - 31st, 2023
Latest in immunological technologies that can treat, control, and prevent cancer
Choosing Wisely in radiology Tanzania
CheckMate 649 biomarker analyses of NIVO + IPI vs chemo for patients with GC/GEJC/EAC